A Phase I, Open-Label, Randomized Cross-Over, 2-Period, 2-Way Interaction Trial to Investigate the Pharmacokinetic Interaction Between Lopinavir/Ritonavir and TMC125 Both at Steady-State in Healthy Subjects.

Trial Profile

A Phase I, Open-Label, Randomized Cross-Over, 2-Period, 2-Way Interaction Trial to Investigate the Pharmacokinetic Interaction Between Lopinavir/Ritonavir and TMC125 Both at Steady-State in Healthy Subjects.

Completed
Phase of Trial: Phase I

Latest Information Update: 01 May 2012

At a glance

  • Drugs Etravirine; Lopinavir/ritonavir
  • Indications HIV-1 infections
  • Focus Pharmacokinetics
  • Sponsors Janssen R&D Ireland
  • Most Recent Events

    • 01 May 2012 Results published in the Journal of Clinical Pharmacology.
    • 11 Nov 2009 Results were presented at EACS 2009.
    • 09 Oct 2009 Actual end date (Dec 2008) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top